Clenbuterol hydrochloride is a selective beta-2 adrenergic agonist originally developed as a bronchodilator for the treatment of asthma. It is not a steroid, SARM, or hormone; it belongs to the sympathomimetic amine class. In the performance context, clenbuterol is primarily used as a thermogenic fat loss agent due to its ability to increase basal metabolic rate, stimulate lipolysis, and preserve lean muscle mass during caloric deficits. Clenbuterol also has mild anabolic properties in animal models (particularly in livestock, where it is used illicitly as a growth promoter), though these effects are much less pronounced in humans. It remains one of the most popular cutting compounds worldwide.
Notes
Clenbuterol is approved for asthma treatment in some countries (Europe, Asia) but is NOT FDA-approved in the United States for any human use. It is a prescription veterinary drug in the US. It is classified as a performance-enhancing drug and banned by WADA. The cardiac risks should not be underestimated, especially with chronic use.
Clenbuterol binds to beta-2 adrenergic receptors on cell surfaces, activating adenylyl cyclase and increasing intracellular cyclic AMP (cAMP). Elevated cAMP activates protein kinase A (PKA), which phosphorylates hormone-sensitive lipase (HSL) and perilipin, directly stimulating the breakdown of stored triglycerides into free fatty acids (lipolysis). In brown and beige adipose tissue, cAMP also activates uncoupling protein 1 (UCP1), generating heat instead of ATP (thermogenesis). Additional effects include: bronchodilation via airway smooth muscle relaxation, increased heart rate via cardiac beta-1 cross-reactivity, mild anti-catabolic effects through Akt/mTOR pathway activation, and increased oxygen transport capacity.
Clenbuterol is rapidly and almost completely absorbed orally. Peak plasma levels occur at 2-3 hours. The long half-life of 36-48 hours means the compound accumulates with daily dosing, which is why gradual dose titration is critical. Steady-state levels are reached after approximately 5-7 days. Metabolism is hepatic, with the primary metabolite being 4-amino-3,5-dichlorohippuric acid. Approximately 50% is excreted unchanged in urine. The long half-life also means that side effects persist if they occur.
Typical Dose
Start at 20 mcg/day. Increase by 20 mcg every 2-3 days until reaching effective dose. Common effective dose: 80-120 mcg/day. Maximum: 140-160 mcg/day (not recommended for most users). Women typically use 20-100 mcg/day. The gradual titration is essential for assessing individual tolerance.
Frequency
Once or twice daily. Due to the long half-life, once-daily morning dosing is sufficient and preferred to avoid insomnia. Split dosing (AM and early afternoon) is used by some to reduce peak-related side effects.
Administration
Oral tablets (most common), liquid solution, or injectable (rarely used). Tablets are typically 20 mcg or 40 mcg. Oral administration is standard.
Half-Life
36-48 hours (range: 25-39 hours in most studies)
Contraindications
No PCT required. Clenbuterol does not affect the HPTA, testosterone, or any sex hormones. No hormonal recovery is necessary after discontinuation.